3 Einträge gefunden

1. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Kingo, K
   7. Szepietowski, J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Rissler, M
   7. Gathmann, S

   2020 - Forschungsinformationssystem des UKE
3. Continued treatment with secukinumab is associated with high retention or regain of response

   1. Augustin, M
   2. Thaci, D
   3. Eyerich, K
   4. Pinter, A
   5. Radtke, M
   6. Lauffer, F
   7. Mrowietz, U

   2020 - Forschungsinformationssystem des UKE